Table 2.

Total fatty acid profile of BC patients (pre and post) in comparison with controls

Total fatty acid	Controls	Pre-treated BC patients	Post-treated BC patients
C-12: 0	ND	0 ± 0	0.42 ± 0.04
C-14: 0	1.26 ± 0.96	1.34 ± 0.30	2.03 ± 1.06
C-15: 0	0.80 ± 0.13	0.47 ± 0.22	1.86 ± 1.18
C-16: 0	18.2 ± 5.06	22.3 ± 2.57*	20.7 ± 2.73*
C-18: 0	14.6 ± 3.56	23.1 ± 2.43*	22.9 ± 2.36*
C-14: 1	0.80 ± 0.74	1.19 ± 0.60	0.86 ± 0.42
C-16: 1	2.62 ± 1.37	1.72 ± 0.43*	1.34 ± 0.76*
C-18: 1	19.7 ± 2.276	25.4 ± 1.6*	24.6 ± 2.32*
C-18: 2 (n-6)	29.1 ± 3.28	20.64 ± 1.94*	22.1 ± 2.39*
C-18: 3 (n-3)	0.98 ± 0.76	1.69 ± 0.60*	2.36 ± 1.85*
C-20: 3 (n-6)	1.58 ± 0.87	0.55 ± 0.30	0.72 ± 0.69
C-20: 4 (n-6)	7.72 ± 2.42	1.24 ± 0.46*	1.59 ± 0.96*
C-22: 6 (n-3)	0.46 ± 0.30	0.51 ± 0.19	1.15 ± 0.89
C-18:0: C-18:1	0.72 ± 0.24	0.91 ± 0.10	0.93 ± 0.14
C-18:2: C-18:1	1.5 ± 0.28	0.82 ± 0.09	0.91 ± 0.14
C-18:3: C-18:1	0.05 ± 0.03	0.07 ± 0.02	0.10 ± 0.09
n-3: n-6	9.8 ± 3.99	3.4 ± 0.86*	4.62 ± 1.95*
Sat: unsat FA’s	41.0 ± 4.50	26.2 ± 2.02*	29.1 ± 3.22*
D5 Desaturase	7.75 ± 6.02	2.66 ± 1.25*	3.53 ± 3.45*
D6 Desaturase	0.026 ± 0.014	0.05 ± 0.03	0.03 ± 0.02

* p < 0.05 shows the comparison pre and post treated BC patients with controls, ¶ p < 0.05 shows the comparison of pretreated BC patients with post treated BC patients. Values represent mean ± standard deviation of triplicates. The different symbol on the same row indicates the Significant difference at p < 0.05. Lauric acid (C12:0), Myristic acid (C14:1), myristoleic acid (C14:1), Pentadecyclic acid (C15:0), palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), α-linolenic acid (C18:3), C20:3 (Dihomo-γ-linolenic acid), arachidonic acid (C20:4), and docosahexaenoic acid (DHA (C22:6).D5 Desaturase was calculated as 20:4n-6/20:3n-6 ratio.D6 Desaturase was calculated as 20:3n-6/18:2n-6 ratio. Sat: unsat FA’s shows saturated and unsaturated fatty acids ratio